Hypertrophic cardiomyopathy: Management, risk stratification, and prevention of sudden death

Heart

Volumn 87, Issue 2, 2002, Pages 169-176

  McKenna, William J ^a   Behr, Elijah R ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; DISOPYRAMIDE; DIURETIC AGENT; VERAPAMIL;

BLOOD PRESSURE; DEFIBRILLATOR; DISEASE ASSOCIATION; EXERCISE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; SYMPTOMATOLOGY;

EID: 0036153781     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.87.2.169     Document Type: Review

References (23)

1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults
2. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients
3. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
4. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
5. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy
6. Hypertrophic cardiomyopathy and sudden death
7. Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration
8. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy
9. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial
10. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy
11. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population
12. Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study
13. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients
14. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest
15. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
16. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy
17. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
18. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study
19. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy
20. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy
21. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy
22. Sudden death in young athletes
23. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia